Literature DB >> 32059870

Platelet-derived growth factor receptor-alpha-positive myeloid neoplasm presenting as eosinophilic gastrointestinal disease.

Gregory M Constantine1, JeanAnne Ware1, Thomas Brown1, Lauren Thumm2, Natasha Kamal3, Sheila Kumar3, David Kleiner4, Irina Maric5, Amy D Klion6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32059870      PMCID： PMC8456709          DOI： 10.1016/j.jaip.2020.01.055

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  9 in total

1.  Rapid reversion of eosinophilic gastroenteritis associated with FIP1L1-PDGFRA fusion after targeted therapy with imatinib.

Authors:  Vincenzo Pitini; Giuseppe Sturniolo; Vittorio Cavallari; Carmela Arrigo
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

2.  Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness.

Authors:  Amy D Klion; Pierre Noel; Cem Akin; Melissa A Law; D Gary Gilliland; Jan Cools; Dean D Metcalfe; Thomas B Nutman
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

3.  Frequent false-negative FIP1L1-PDGFRA FISH analyses of bone marrow samples from clonal eosinophilia at diagnosis.

Authors:  Linda Olsson-Arvidsson; Anna Norberg; Helene Sjögren; Bertil Johansson
Journal:  Br J Haematol       Date:  2019-12-18       Impact factor: 6.998

4.  Eosinophilic gastrointestinal disorders (EGID) with peripheral eosinophilia: a retrospective review at Mayo Clinic.

Authors:  Joohee Lee; Ross Dierkhising; Tsung-Teh Wu; Jeffrey Alexander; Catherine Weiler
Journal:  Dig Dis Sci       Date:  2011-06-08       Impact factor: 3.199

5.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors:  Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

Review 6.  Gastrointestinal Manifestations of Hypereosinophilic Syndromes and Mast Cell Disorders: a Comprehensive Review.

Authors:  Vivian C Nanagas; Anna Kovalszki
Journal:  Clin Rev Allergy Immunol       Date:  2019-10       Impact factor: 8.667

7.  Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.

Authors:  Princess U Ogbogu; Bruce S Bochner; Joseph H Butterfield; Gerald J Gleich; Johannes Huss-Marp; Jean Emmanuel Kahn; Kristin M Leiferman; Thomas B Nutman; Florian Pfab; Johannes Ring; Marc E Rothenberg; Florence Roufosse; Marie-Helene Sajous; Javed Sheikh; Dagmar Simon; Hans-Uwe Simon; Miguel L Stein; Andrew Wardlaw; Peter F Weller; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

8.  A hypereosinophilic syndrome presenting as eosinophilic colitis.

Authors:  Young Woo Jeon; Su Jin Hong; Hwa Jong Kim; Jae Pil Han; Hee Kyung Kim; Bong Min Ko; Sung Kyu Park; Moon Sung Lee
Journal:  Clin Endosc       Date:  2012-11-30

9.  The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 Cases.

Authors:  Fanny Legrand; Aline Renneville; Elizabeth MacIntyre; Samuel Mastrilli; Felix Ackermann; Jean Michel Cayuela; Philippe Rousselot; Aline Schmidt-Tanguy; Olivier Fain; Marc Michel; Jean-Pierre de Jaureguiberry; Pierre-Yves Hatron; Pascale Cony-Makhoul; Didier Lefranc; Damien Sène; Vincent Cottin; Mohamed Hamidou; Olivier Lidove; André Baruchel; Sylvain Dubucquoi; Olivier Bletry; Claude Preudhomme; Monique Capron; Lionel Prin; Jean Emmanuel Kahn
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889
  9 in total
  1 in total

1.  Elevated Basal Serum Tryptase: Disease Distribution and Variability in a Regional Health System.

Authors:  Aubri M Waters; Hyun J Park; Andrew L Weskamp; Allyson Mateja; Megan E Kachur; Jonathan J Lyons; Benjamin J Rosen; Nathan A Boggs
Journal:  J Allergy Clin Immunol Pract       Date:  2022-01-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.